Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended & Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in its securities, Medico Remedies has informed that the 'Trading Window' for dealing in the equity shares of the Company will be closed for all Insiders, Designated Persons and their immediate relatives from 1st January, 2023 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial
Results for the quarter ended 31st December, 2022.
The above information is a part of company’s filings submitted to BSE.
